Joe Parker, MD: PBI-4050 Demonstrates Promising Efficacy Results for IPF Treatment

June 6, 2018
Prometic Life Science's senior director details the promising efficacy PBI-4050 alone or in combination with nintedanib demonstrated for treatment of IPF, suggesting the potential as an antifibrotic, anti-inflammatory and pro-tissue repair mechanism.